{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T00:47:14Z","timestamp":1794271634853,"version":"4.9.0"},"reference-count":182,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T00:00:00Z","timestamp":1747785600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Epigenetic dysregulation has emerged as an important player in the pathobiology of neurodegenerative diseases (NDDs), such as Alzheimer\u2019s, Parkinson\u2019s, and Huntington\u2019s diseases. Aberrant DNA methylation, histone modifications, and dysregulated non-coding RNAs have been shown to contribute to neuronal dysfunction and degeneration. These alterations are often exacerbated by environmental toxins, which induce oxidative stress, inflammation, and genomic instability. Reversing epigenetic aberrations may offer an avenue for restoring brain mechanisms and mitigating neurodegeneration. Herein, we revisit the evidence suggesting the ameliorative effects of epigenetic modulators in toxin-induced models of NDDs. The restoration of normal gene expressions, the improvement of neuronal function, and the reduction in pathological markers by histone deacetylase (HDAC) and DNA methyltransferase (DNMT) inhibitors have been demonstrated in preclinical models of NDDs. Encouragingly, in clinical trials of Alzheimer\u2019s disease (AD), HDAC inhibitors have caused improvements in cognition and memory. Combining these beneficial effects of epigenetic modulators with neuroprotective agents and the clearance of misfolded amyloid proteins may offer synergistic benefits. Reinforced by the emerging methods for more effective and brain-specific delivery, reversibility, and safety considerations, epigenetic modulators are anticipated to minimize systemic toxicity and yield more favorable outcomes in NDDs. In summary, although still in their infancy, epigenetic modulators offer an integrated strategy to address the multifactorial nature of NDDs, altering their therapeutic landscape.<\/jats:p>","DOI":"10.3390\/ijms26104929","type":"journal-article","created":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T06:31:27Z","timestamp":1747809087000},"page":"4929","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Reversing Epigenetic Dysregulation in Neurodegenerative Diseases: Mechanistic and Therapeutic Considerations"],"prefix":"10.3390","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0188-9836","authenticated-orcid":false,"given":"David B.","family":"Olawade","sequence":"first","affiliation":[{"name":"Department of Allied and Public Health, School of Health, Sport and Bioscience, University of East London, London E16 2RD, UK"},{"name":"Department of Research and Innovation, Medway NHS Foundation Trust, Gillingham ME7 5NY, UK"},{"name":"Department of Public Health, York St John University, London E14 2BA, UK"},{"name":"School of Health and Care Management, Arden University, Arden House, Middlemarch Park, Coventry CV3 4FJ, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7029-7335","authenticated-orcid":false,"given":"Intishar","family":"Rashad","sequence":"additional","affiliation":[{"name":"Department of Acute Medicine, Medway NHS Foundation Trust, Gillingham ME7 5NY, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eghosasere","family":"Egbon","sequence":"additional","affiliation":[{"name":"Department of Tissue Engineering and Regenerative Medicine, Faculty of Life Science Engineering, FH Technikum, 1200 Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Teke","sequence":"additional","affiliation":[{"name":"Department of Research and Innovation, Medway NHS Foundation Trust, Gillingham ME7 5NY, UK"},{"name":"Faculty of Medicine, Health and Social Care, Canterbury Christ Church University, Canterbury CT1 1QU, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9522-4159","authenticated-orcid":false,"given":"Saak Victor","family":"Ovsepian","sequence":"additional","affiliation":[{"name":"Faculty of Engineering and Science, University of Greenwich London, Chatham Maritime ME4 4TB, UK"},{"name":"Faculty of Medicine, Tbilisi State University, Tbilisi 0177, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2512-6131","authenticated-orcid":false,"given":"Stergios","family":"Boussios","sequence":"additional","affiliation":[{"name":"Department of Research and Innovation, Medway NHS Foundation Trust, Gillingham ME7 5NY, UK"},{"name":"Faculty of Medicine, Health and Social Care, Canterbury Christ Church University, Canterbury CT1 1QU, UK"},{"name":"Faculty of Life Sciences & Medicine, School of Cancer & Pharmaceutical Sciences, King\u2019s College London, London WC2R 2LS, UK"},{"name":"Kent Medway Medical School, University of Kent, Canterbury CT2 7LX, UK"},{"name":"AELIA Organization, 9th Km Thessaloniki\u2014Thermi, 57001 Thessaloniki, Greece"},{"name":"Department of Medical Oncology, Medway NHS Foundation Trust, Gillingham ME7 5NY, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,5,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Alkahtani, S., Al-Johani, N.S., and Alarifi, S. (2023). Mechanistic Insights, Treatment Paradigms, and Clinical Progress in Neurological Disorders: Current and Future Prospects. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24021340"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Kakoti, B.B., Bezbaruah, R., and Ahmed, N. (2022). Therapeutic drug repositioning with special emphasis on neurodegenerative diseases: Threats and issues. Front. Pharmacol., 13.","DOI":"10.3389\/fphar.2022.1007315"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/s41392-024-01911-3","article-title":"Recent advances in Alzheimer\u2019s disease: Mechanisms, clinical trials and new drug development strategies","volume":"9","author":"Zhang","year":"2024","journal-title":"Signal. Transduct. Target. Ther."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e14548","DOI":"10.1111\/cns.14548","article-title":"Neurotropic virus infection and neurodegenerative diseases: Potential roles of autophagy pathway","volume":"30","author":"Zhao","year":"2024","journal-title":"CNS Neurosci. Ther."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.mrfmmm.2008.10.011","article-title":"Genetics, environmental factors and the emerging role of epigenetics in neurodegenerative diseases","volume":"667","author":"Migliore","year":"2009","journal-title":"Mutat. Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/desc.12282","article-title":"Development and the epigenome: The \u2018synapse\u2019 of gene-environment interplay","volume":"18","author":"Boyce","year":"2015","journal-title":"Dev. Sci."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/hdy.2010.54","article-title":"Epigenetics and gene expression","volume":"105","author":"Gibney","year":"2010","journal-title":"Heredity"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Bure, I.V., Nemtsova, M.V., and Kuznetsova, E.B. (2022). Histone Modifications and Non-Coding RNAs: Mutual Epigenetic Regulation and Role in Pathogenesis. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23105801"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/npp.2012.124","article-title":"Histone regulation in the CNS: Basic principles of epigenetic plasticity","volume":"38","author":"Maze","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Wendimu, M.Y., and Hooks, S.B. (2022). Microglia Phenotypes in Aging and Neurodegenerative Diseases. Cells, 11.","DOI":"10.3390\/cells11132091"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"De Plano, L.M., Saitta, A., Oddo, S., and Caccamo, A. (2024). Epigenetic Changes in Alzheimer\u2019s Disease: DNA Methylation and Histone Modification. Cells, 13.","DOI":"10.3390\/cells13080719"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41582-019-0244-7","article-title":"Ageing as a risk factor for neurodegenerative disease","volume":"15","author":"Hou","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Dogaru, B.G., and Munteanu, C. (2023). The Role of Hydrogen Sulfide (H2S) in Epigenetic Regulation of Neurodegenerative Diseases: A Systematic Review. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241612555"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Olufunmilayo, E.O., and Holsinger, R.M.D. (2023). Roles of Non-Coding RNA in Alzheimer\u2019s Disease Pathophysiology. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241512498"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1002\/1873-3468.14205","article-title":"Transposable elements as new players in neurodegenerative diseases","volume":"595","author":"Znaidi","year":"2021","journal-title":"FEBS Lett."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Angelopoulou, E., Paudel, Y.N., Papageorgiou, S.G., and Piperi, C. (2022). Environmental Impact on the Epigenetic Mechanisms Underlying Parkinson\u2019s Disease Pathogenesis: A Narrative Review. Brain Sci., 12.","DOI":"10.3390\/brainsci12020175"},{"key":"ref_17","first-page":"5491812","article-title":"Epigenetics and Neural Circuitry Landscape of Psychotherapeutic Interventions","volume":"2017","author":"Miller","year":"2017","journal-title":"Psychiatry J."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/s41392-022-01211-8","article-title":"Epigenetic regulation of aging: Implications for interventions of aging and diseases","volume":"7","author":"Wang","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Majchrzak-Celi\u0144ska, A., Warych, A., and Szoszkiewicz, M. (2021). Novel Approaches to Epigenetic Therapies: From Drug Combinations to Epigenetic Editing. Genes, 12.","DOI":"10.3390\/genes12020208"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Clemente-Su\u00e1rez, V.J., Redondo-Fl\u00f3rez, L., Beltr\u00e1n-Velasco, A.I., Ramos-Campo, D.J., Belinch\u00f3n-deMiguel, P., Martinez-Guardado, I., Dalamitros, A.A., Y\u00e1\u00f1ez-Sep\u00falveda, R., Mart\u00edn-Rodr\u00edguez, A., and Tornero-Aguilera, J.F. (2023). Mitochondria and Brain Disease: A Comprehensive Review of Pathological Mechanisms and Therapeutic Opportunities. Biomedicines, 11.","DOI":"10.3390\/biomedicines11092488"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13024-022-00524-0","article-title":"Solving neurodegeneration: Common mechanisms and strategies for new treatments","volume":"17","author":"Wareham","year":"2022","journal-title":"Mol. Neurodegener."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Toader, C., Dobrin, N., Brehar, F.M., Popa, C., Covache-Busuioc, R.A., Glavan, L.A., Costin, H.P., Bratu, B.G., Corlatescu, A.D., and Popa, A.A. (2023). From Recognition to Remedy: The Significance of Biomarkers in Neurodegenerative Disease Pathology. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms242216119"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Shi, F., He, Y., Chen, Y., Yin, X., Sha, X., and Wang, Y. (2021). Comparative Analysis of Multiple Neurodegenerative Diseases Based on Advanced Epigenetic Aging Brain. Front. Genet., 12.","DOI":"10.3389\/fgene.2021.657636"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pneurobio.2009.01.007","article-title":"Neural cell cycle dysregulation and central nervous system diseases","volume":"89","author":"Wang","year":"2009","journal-title":"Prog. Neurobiol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"771","DOI":"10.2174\/1568026616666160414124628","article-title":"Epigenetic Basis of Neuronal and Synaptic Plasticity","volume":"17","author":"Karpova","year":"2017","journal-title":"Curr. Top. Med. Chem."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"108306","DOI":"10.1016\/j.neuropharm.2020.108306","article-title":"BET bromodomains as novel epigenetic targets for brain health and disease","volume":"181","author":"Singh","year":"2020","journal-title":"Neuropharmacology"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Chen, Y., Mateski, J., Gerace, L., Wheeler, J., Burl, J., Prakash, B., Svedin, C., Amrick, R., and Adams, B.D. (2024). Non-coding RNAs and neuroinflammation: Implications for neurological disorders. Exp. Biol. Med., 249.","DOI":"10.3389\/ebm.2024.10120"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Xia, M., Wang, B., Wang, Z., Zhang, X., and Wang, X. (2021). Epigenetic Regulation of NK Cell-Mediated Antitumor Immunity. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.672328"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s00018-022-04536-3","article-title":"The heterogeneity of microglial activation and its epigenetic and non-coding RNA regulations in the immunopathogenesis of neurodegenerative diseases","volume":"79","author":"Li","year":"2022","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ibneur.2022.12.002","article-title":"The role of DNA methylation in progression of neurological disorders and neurodegenerative diseases as well as the prospect of using DNA methylation inhibitors as therapeutic agents for such disorders","volume":"14","author":"Rasmi","year":"2022","journal-title":"IBRO Neurosci. Rep."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s10571-020-00979-z","article-title":"Epigenetic Changes and Its Intervention in Age-Related Neurodegenerative Diseases","volume":"42","author":"Makpol","year":"2022","journal-title":"Cell. Mol. Neurobiol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/s41416-024-02655-1","article-title":"Navigating therapeutic strategies: HPV classification in head and neck cancer","volume":"131","author":"Tabatabaeian","year":"2024","journal-title":"Br. J. Cancer."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1016\/j.neurobiolaging.2008.12.005","article-title":"Epigenetic changes in Alzheimer\u2019s disease: Decrements in DNA methylation and dynamin-like protein 1 isoforms","volume":"31","author":"Mastroeni","year":"2010","journal-title":"Neurobiol. Aging."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1038\/nn.3786","article-title":"Alzheimer\u2019s disease: Early alterations in brain DNA methylation at ANK1, BIN1, RHBDF2 and other loci","volume":"17","author":"Srivastava","year":"2014","journal-title":"Nat. Neurosci."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.4161\/epi.21975","article-title":"Histone phosphorylation: A chromatin modification involved in diverse nuclear events","volume":"7","author":"Rossetto","year":"2012","journal-title":"Epigenetics"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/s41580-021-00441-y","article-title":"Modulation of cellular processes by histone and non-histone protein acetylation","volume":"23","author":"Shvedunova","year":"2022","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.bbadis.2017.11.004","article-title":"Epigenetic regulation of astrocyte function in neuroinflammation and neurodegeneration","volume":"1864","author":"Neal","year":"2018","journal-title":"Biochim. Biophys. Acta. Mol. Basis. Dis."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1007\/s12035-014-8715-8","article-title":"Transcription, epigenetics and ameliorative strategies in Huntington\u2019s Disease: A genome-wide perspective","volume":"51","author":"Valor","year":"2015","journal-title":"Mol. Neurobiol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nature10849","article-title":"An epigenetic blockade of cognitive functions in the neurodegenerating brain","volume":"483","author":"Rei","year":"2012","journal-title":"Nature"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/s41593-018-0291-1","article-title":"Epigenome-wide study uncovers large-scale changes in histone acetylation in the Alzheimer\u2019s disease entorhinal cortex","volume":"22","author":"Klein","year":"2019","journal-title":"Nat. Neurosci."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.neulet.2018.03.052","article-title":"Inhibition of microRNA-34a protects against propofol anesthesia-induced neurotoxicity and cognitive dysfunction via the MAPK\/ERK signaling pathway","volume":"675","author":"Li","year":"2018","journal-title":"Neurosci. Lett."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.4103\/1673-5374.221147","article-title":"MicroRNAs in Parkinson\u2019s disease and emerging therapeutic targets","volume":"12","author":"Martinez","year":"2017","journal-title":"Neural. Regen. Res."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"4299","DOI":"10.1038\/emboj.2011.327","article-title":"microRNA-34c is a novel target to treat dementias","volume":"30","author":"Zovoilis","year":"2011","journal-title":"EMBO J."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Maciotta, S., Meregalli, M., and Torrente, Y. (2013). The involvement of microRNAs in neurodegenerative diseases. Front. Cell. Neurosci., 7.","DOI":"10.3389\/fncel.2013.00265"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.nbd.2007.11.001","article-title":"A microRNA-based gene dysregulation pathway in Huntington\u2019s disease","volume":"29","author":"Johnson","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Nabi, M., and Tabassum, N. (2022). Role of Environmental Toxicants on Neurodegenerative Disorders. Front. Toxicol., 4.","DOI":"10.3389\/ftox.2022.837579"},{"key":"ref_47","unstructured":"K\u00f6hler, N. (2014). PubMed Commons: Beschreibung und Analyse von PubMeds neuer Kommentarfunktion. Bibliometr.\u2013Prax. Und Forschung, 3."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.envpol.2017.11.083","article-title":"Cortex and hippocampus DNA epigenetic response to a long-term arsenic exposure via drinking water","volume":"234","author":"Du","year":"2018","journal-title":"Environ. Pollut."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jprot.2018.06.020","article-title":"Differential protein expression of hippocampal cells associated with heavy metals (Pb, As, and MeHg) neurotoxicity: Deepening into the molecular mechanism of neurodegenerative diseases","volume":"187","author":"Karri","year":"2018","journal-title":"J. Proteom."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"165272","DOI":"10.1016\/j.scitotenv.2023.165272","article-title":"Cellular and physiological mechanisms of halogenated and organophosphorus flame retardant toxicity","volume":"897","author":"Khani","year":"2023","journal-title":"Sci. Total. Environ."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Wang, R., Sun, H., Wang, G., and Ren, H. (2020). Imbalance of Lysine Acetylation Contributes to the Pathogenesis of Parkinson\u2019s Disease. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21197182"},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Huang, M., Bargues-Carot, A., Riaz, Z., Wickham, H., Zenitsky, G., Jin, H., Anantharam, V., Kanthasamy, A., and Kanthasamy, A.G. (2022). Impact of Environmental Risk Factors on Mitochondrial Dysfunction, Neuroinflammation, Protein Misfolding, and Oxidative Stress in the Etiopathogenesis of Parkinson\u2019s Disease. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms231810808"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.toxrep.2024.04.010","article-title":"Genetic and epigenetic modulations in toxicity: The two-sided roles of heavy metals and polycyclic aromatic hydrocarbons from the environment","volume":"12","author":"Adegbola","year":"2024","journal-title":"Toxicol. Rep."},{"key":"ref_54","first-page":"7526592","article-title":"Neurodevelopmental Disorders and Environmental Toxicants: Epigenetics as an Underlying Mechanism","volume":"2017","author":"Tran","year":"2017","journal-title":"Int. J. Genom."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"174450","DOI":"10.1016\/j.scitotenv.2024.174450","article-title":"Neurotoxicity of fine and ultrafine particulate matter: A comprehensive review using a toxicity pathway-oriented adverse outcome pathway framework","volume":"947","author":"Qin","year":"2024","journal-title":"Sci. Total. Environ."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/s41582-022-00714-w","article-title":"Gene-environment interactions in Alzheimer disease: The emerging role of epigenetics","volume":"18","author":"Migliore","year":"2022","journal-title":"Nat. Rev. Neurol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1124\/pr.110.003046","article-title":"Prevention or modification of epileptogenesis after brain insults: Experimental approaches and translational research","volume":"62","author":"Brandt","year":"2010","journal-title":"Pharmacol. Rev."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Babar, Q., Saeed, A., Tabish, T.A., Pricl, S., Townley, H., and Thorat, N. (2022). Novel epigenetic therapeutic strategies and targets in cancer. Biochim. Biophys. Acta. Mol. Basis. Dis., 1868.","DOI":"10.1016\/j.bbadis.2022.166552"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/acn3.147","article-title":"The promise and perils of HDAC inhibitors in neurodegeneration","volume":"2","author":"Didonna","year":"2015","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.2174\/1570159X22666240128002056","article-title":"Emerging Neuroprotective Strategies: Unraveling the Potential of HDAC Inhibitors in Traumatic Brain Injury Management","volume":"22","author":"Ye","year":"2024","journal-title":"Curr. Neuropharmacol."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Upadhyay, R.K. (2014). Drug delivery systems, CNS protection, and the blood brain barrier. Biomed. Res. Int., 2014.","DOI":"10.1155\/2014\/869269"},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Satapathy, M.K., Yen, T.L., Jan, J.S., Tang, R.D., Wang, J.Y., Taliyan, R., and Yang, C.H. (2021). Solid Lipid Nanoparticles (SLNs): An Advanced Drug Delivery System Targeting Brain through BBB. Pharmaceutics, 13.","DOI":"10.3390\/pharmaceutics13081183"},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Al-Jipouri, A., Almurisi, S.H., Al-Japairai, K., Bakar, L.M., and Doolaanea, A.A. (2023). Liposomes or Extracellular Vesicles: A Comprehensive Comparison of Both Lipid Bilayer Vesicles for Pulmonary Drug Delivery. Polymers, 15.","DOI":"10.3390\/polym15020318"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1007\/s13346-018-0552-2","article-title":"Transferrin receptors-targeting nanocarriers for efficient targeted delivery and transcytosis of drugs into the brain tumors: A review of recent advancements and emerging trends","volume":"8","author":"Choudhury","year":"2018","journal-title":"Drug Deliv. Transl. Res."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Rittiner, J., Cumaran, M., Malhotra, S., and Kantor, B. (2022). Therapeutic modulation of gene expression in the disease state: Treatment strategies and approaches for the development of next-generation of the epigenetic drugs. Front. Bioeng. Biotechnol., 10.","DOI":"10.3389\/fbioe.2022.1035543"},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Askenase, P.W. (2021). Ancient Evolutionary Origin and Properties of Universally Produced Natural Exosomes Contribute to Their Therapeutic Superiority Compared to Artificial Nanoparticles. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22031429"},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Boussios, S., Devo, P., Goodall, I.C.A., Sirlantzis, K., Ghose, A., Shinde, S.D., Papadopoulos, V., Sanchez, E., Rassy, E., and Ovsepian, S.V. (2023). Exosomes in the Diagnosis and Treatment of Renal Cell Cancer. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241814356"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"15330338241275403","DOI":"10.1177\/15330338241275403","article-title":"Exosomes in Renal Cell Cancer: Diagnostic and Therapeutic Nanovehicles","volume":"23","author":"Boussios","year":"2024","journal-title":"Technol. Cancer Res. Treat."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Hamid, Y., Rabbani, R.D., Afsara, R., Nowrin, S., Ghose, A., Papadopoulos, V., Sirlantzis, K., Ovsepian, S.V., and Boussios, S. (2025). Exosomal Liquid Biopsy in Prostate Cancer: A Systematic Review of Biomarkers for Diagnosis, Prognosis, and Treatment Response. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26020802"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/npp.2012.154","article-title":"The role of histone acetylation in cocaine-induced neural plasticity and behavior","volume":"38","author":"Rogge","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.cytogfr.2024.06.002","article-title":"The impact of cytokines in neuroinflammation-mediated stroke","volume":"78","author":"Kumari","year":"2024","journal-title":"Cytokine Growth Factor Rev."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1080\/13543776.2019.1708901","article-title":"A patent review of histone deacetylase 6 inhibitors in neurodegenerative diseases (2014-2019)","volume":"30","author":"Shen","year":"2020","journal-title":"Expert Opin. Ther. Pat."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"926","DOI":"10.2174\/1570159X17666181227165722","article-title":"Valproic Acid and Epilepsy: From Molecular Mechanisms to Clinical Evidences","volume":"17","author":"Romoli","year":"2019","journal-title":"Curr. Neuropharmacol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"158","DOI":"10.2174\/1570159X19666210609160017","article-title":"Understanding the Role of Histone Deacetylase and their Inhibitors in Neurodegenerative Disorders: Current Targets and Future Perspective","volume":"20","author":"Kumar","year":"2022","journal-title":"Curr. Neuropharmacol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/978-3-319-71779-1_17","article-title":"Planning Future Clinical Trials for Machado-Joseph Disease","volume":"1049","author":"Saute","year":"2018","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nrg.2017.80","article-title":"The DNA methyltransferase family: A versatile toolkit for epigenetic regulation","volume":"19","author":"Lyko","year":"2018","journal-title":"Nat. Rev. Genet."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1038\/npp.2009.197","article-title":"Inhibitors of class 1 histone deacetylases reverse contextual memory deficits in a mouse model of Alzheimer\u2019s disease","volume":"35","author":"Kilgore","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"15564","DOI":"10.1073\/pnas.0804249105","article-title":"The HDAC inhibitor 4b ameliorates the disease phenotype and transcriptional abnormalities in Huntington\u2019s disease transgenic mice","volume":"105","author":"Thomas","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ijcard.2016.11.204","article-title":"Treatment of cardiovascular pathology with epigenetically active agents: Focus on natural and synthetic inhibitors of DNA methylation and histone deacetylation","volume":"227","author":"Chistiakov","year":"2017","journal-title":"Int. J. Cardiol."},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Ciechomska, M., Roszkowski, L., and Maslinski, W. (2019). DNA Methylation as a Future Therapeutic and Diagnostic Target in Rheumatoid Arthritis. Cells, 8.","DOI":"10.3390\/cells8090953"},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Teijido, O., and Cacabelos, R. (2018). Pharmacoepigenomic Interventions as Novel Potential Treatments for Alzheimer\u2019s and Parkinson\u2019s Diseases. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19103199"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"e2201740","DOI":"10.1002\/advs.202201740","article-title":"Delivering the Promise of Gene Therapy with Nanomedicines in Treating Central Nervous System Diseases","volume":"9","author":"Luo","year":"2022","journal-title":"Adv. Sci."},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Kular, L., and Jagodic, M. (2019). \u2018DNA Methylation in Multiple Sclerosis\u2019. The DNA, RNA, and Histone Methylomes, Springer.","DOI":"10.1007\/978-3-030-14792-1_8"},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Gladkova, M.G., Leidmaa, E., and Anderzhanova, E.A. (2023). Epidrugs in the Therapy of Central Nervous System Disorders: A Way to Drive on?. Cells, 12.","DOI":"10.3390\/cells12111464"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1093\/brain\/awy354","article-title":"Inhibition of EHMT1\/2 rescues synaptic and cognitive functions for Alzheimer\u2019s disease","volume":"142","author":"Zheng","year":"2019","journal-title":"Brain"},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Wang, Z., Leng, Y., Wang, J., Liao, H.M., Bergman, J., Leeds, P., Kozikowski, A., and Chuang, D.M. (2016). Tubastatin A, an HDAC6 inhibitor, alleviates stroke-induced brain infarction and functional deficits: Potential roles of \u03b1-tubulin acetylation and FGF-21 up-regulation. Sci. Rep., 6.","DOI":"10.1038\/srep19626"},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Mielcarek, M., Landles, C., Weiss, A., Bradaia, A., Seredenina, T., Inuabasi, L., Osborne, F.G., Wadel, K., Touller, C., and Butler, R. (2013). HDAC4 reduction: A novel therapeutic strategy to target cytoplasmic huntingtin and ameliorate neurodegeneration. PLoS Biol., 11.","DOI":"10.1371\/journal.pbio.1001717"},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Toma, L., Sanda, G.M., Niculescu, L.S., Deleanu, M., Sima, A.V., and Stancu, C.S. (2020). Phenolic Compounds Exerting Lipid-Regulatory, Anti-Inflammatory and Epigenetic Effects as Complementary Treatments in Cardiovascular Diseases. Biomolecules, 10.","DOI":"10.3390\/biom10040641"},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"D\u2019Egidio, F., Castelli, V., Cimini, A., and d\u2019Angelo, M. (2023). Cell Rearrangement and Oxidant\/Antioxidant Imbalance in Huntington\u2019s Disease. Antioxidants, 12.","DOI":"10.3390\/antiox12030571"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"e13012","DOI":"10.1111\/bpa.13012","article-title":"The epigenetic mechanisms involved in mitochondrial dysfunction: Implication for Parkinson\u2019s disease","volume":"32","author":"Chen","year":"2022","journal-title":"Brain Pathol."},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Landgrave-G\u00f3mez, J., Mercado-G\u00f3mez, O., and Guevara-Guzm\u00e1n, R. (2015). Epigenetic mechanisms in neurological and neurodegenerative diseases. Front. Cell. Neurosci., 9.","DOI":"10.3389\/fncel.2015.00058"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"4127","DOI":"10.1093\/hmg\/ddt261","article-title":"Method for widespread microRNA-155 inhibition prolongs survival in ALS-model mice","volume":"22","author":"Koval","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"13052","DOI":"10.1073\/pnas.0906277106","article-title":"Repression of alpha-synuclein expression and toxicity by microRNA-7","volume":"106","author":"Junn","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"14835","DOI":"10.1523\/JNEUROSCI.3030-10.2010","article-title":"MicroRNA loss enhances learning and memory in mice","volume":"30","author":"Konopka","year":"2010","journal-title":"J. Neurosci."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"5981","DOI":"10.1021\/acs.molpharmaceut.3c00610","article-title":"Advances in the Delivery and Development of Epigenetic Therapeutics for the Treatment of Cancer","volume":"20","author":"Ghosh","year":"2023","journal-title":"Mol. Pharm."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"107247","DOI":"10.1016\/j.phrs.2024.107247","article-title":"Advancing personalized medicine in neurodegenerative diseases: The role of epigenetics and pharmacoepigenomics in pharmacotherapy","volume":"205","author":"Guerrero","year":"2024","journal-title":"Pharmacol. Res."},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Wood, I.C. (2018). The Contribution and Therapeutic Potential of Epigenetic Modifications in Alzheimer\u2019s Disease. Front. Neurosci., 12.","DOI":"10.3389\/fnins.2018.00649"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"543","DOI":"10.2217\/nmt-2019-0034","article-title":"Alzheimer\u2019s disease: The potential of epigenetic treatments and current clinical candidates","volume":"10","author":"Coneys","year":"2020","journal-title":"Neurodegener. Dis. Manag."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"112","DOI":"10.14336\/AD.2022.0706","article-title":"Prelimbic Cortical Stimulation with L-methionine Enhances Cognition through Hippocampal DNA Methylation and Neuroplasticity Mechanisms","volume":"14","author":"Poon","year":"2023","journal-title":"Aging Dis."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.pharmthera.2013.05.010","article-title":"Epigenetic targeting of histone deacetylase: Therapeutic potential in Parkinson\u2019s disease?","volume":"140","author":"Harrison","year":"2013","journal-title":"Pharmacol. Ther."},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Blesa, J., and Przedborski, S. (2014). Parkinson\u2019s disease: Animal models and dopaminergic cell vulnerability. Front. Neuroanat., 8.","DOI":"10.3389\/fnana.2014.00155"},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Hontecillas-Prieto, L., Flores-Campos, R., Silver, A., de \u00c1lava, E., Hajji, N., and Garc\u00eda-Dom\u00ednguez, D.J. (2020). Synergistic Enhancement of Cancer Therapy Using HDAC Inhibitors: Opportunity for Clinical Trials. Front. Genet., 11.","DOI":"10.3389\/fgene.2020.578011"},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Banik, D., Moufarrij, S., and Villagra, A. (2019). Immunoepigenetics Combination Therapies: An Overview of the Role of HDACs in Cancer Immunotherapy. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20092241"},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Dash, P.K., Orsi, S.A., Zhang, M., Grill, R.J., Pati, S., Zhao, J., and Moore, A.N. (2010). Valproate administered after traumatic brain injury provides neuroprotection and improves cognitive function in rats. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0011383"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"17588359231220511","DOI":"10.1177\/17588359231220511","article-title":"The role of aberrant DNA methylation in cancer initiation and clinical impacts","volume":"16","author":"Geissler","year":"2024","journal-title":"Ther. Adv. Med. Oncol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"969","DOI":"10.2217\/epi-2018-0014","article-title":"Brain, behavior and the journey towards neuroepigenetic therapeutics","volume":"11","author":"Wani","year":"2019","journal-title":"Epigenomics"},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Amin, S., and Bathe, O.F. (2016). Response biomarkers: Re-envisioning the approach to tailoring drug therapy for cancer. BMC Cancer., 16.","DOI":"10.1186\/s12885-016-2886-9"},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"Coyle, K.M., Boudreau, J.E., and Marcato, P. (2017). Genetic Mutations and Epigenetic Modifications: Driving Cancer and Informing Precision Medicine. Biomed. Res. Int., 2017.","DOI":"10.1155\/2017\/9620870"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jconrel.2022.10.018","article-title":"Nucleic acid therapies for CNS diseases: Pathophysiology, targets, barriers, and delivery strategies","volume":"352","author":"Padmakumar","year":"2022","journal-title":"J. Control. Release"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1001\/archneur.55.11.1449","article-title":"Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease","volume":"55","author":"Clarke","year":"1998","journal-title":"Arch. Neurol."},{"key":"ref_111","first-page":"1471","article-title":"Homocysteine, vitamin B6 and vascular disease in the era of folic acid fortification","volume":"58","author":"Miller","year":"2002","journal-title":"Nutr. Rev."},{"key":"ref_112","doi-asserted-by":"crossref","unstructured":"Smith, A.D., Smith, S.M., de Jager, C.A., Whitbread, P., Johnston, C., Agacinski, G., Oulhaj, A., Bradley, K.M., Jacoby, R., and Refsum, H. (2010). Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: A randomized controlled trial. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0012244"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"9523","DOI":"10.1073\/pnas.1301816110","article-title":"Preventing Alzheimer\u2019s disease-related gray matter atrophy by B-vitamin treatment","volume":"110","author":"Douaud","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1089\/ars.2011.4368","article-title":"Folate, homocysteine, vitamin B12, and polymorphisms of genes participating in one-carbon metabolism in late-onset Alzheimer\u2019s disease patients and healthy controls","volume":"17","author":"Tannorella","year":"2012","journal-title":"Antioxid. Redox. Signal."},{"key":"ref_115","first-page":"72","article-title":"Folic acid deficiency enhances abeta accumulation in APP\/PS1 mice brain and decreases amyloid-associated miRNAs expression","volume":"35","author":"Liu","year":"2016","journal-title":"J. Nutr. Biochem."},{"key":"ref_116","first-page":"835","article-title":"Dietary supplementation with S-adenosyl methionine delayed amyloid-\u03b2 and tau pathology in 3xTg-AD mice","volume":"64","author":"Lee","year":"2018","journal-title":"J. Alzheimers Dis."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"3290","DOI":"10.1073\/pnas.94.7.3290","article-title":"Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: Implications for cancer and neuronal damage","volume":"94","author":"Blount","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0166-2236(03)00032-8","article-title":"Folate and homocysteine metabolism in neural plasticity and neurodegenerative disorders","volume":"26","author":"Mattson","year":"2003","journal-title":"Trends Neurosci."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1523\/JNEUROSCI.22-05-01752.2002","article-title":"Folic acid deficiency and homocysteine impair DNA repair in hippocampal neurons and sensitize them to amyloid toxicity in experimental models of Alzheimer\u2019s disease","volume":"22","author":"Kruman","year":"2002","journal-title":"J. Neurosci."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.nbd.2017.04.001","article-title":"B-vitamin and choline supplementation increases neuroplasticity and recovery after stroke","volume":"103","author":"Jadavji","year":"2017","journal-title":"Neurobiol. Dis."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1139\/cjpp-2020-0507","article-title":"Mild hyperhomocysteinemia induces blood\u2013brain barrier dysfunction but not neuroinflammation in the cerebral cortex and hippocampus of wild-type mice","volume":"99","author":"Chu","year":"2021","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.neurobiolaging.2009.02.013","article-title":"Changes in Presenilin 1 gene methylation pattern in diet-induced B vitamin deficiency","volume":"32","author":"Fuso","year":"2011","journal-title":"Neurobiol. Aging"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1097\/JGP.0b013e3181f17eed","article-title":"Is high homocysteine level a risk factor for cognitive decline in elderly? A systematic review, meta-analysis, and meta-regression","volume":"19","author":"Ho","year":"2011","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1086\/321262","article-title":"Homocysteine metabolism in children with Down syndrome: In vitro modulation","volume":"69","author":"Pogribna","year":"2001","journal-title":"Am. J. Hum. Genet."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.pneurobio.2010.01.002","article-title":"Epigenetic regulation in the pathophysiology of Alzheimer\u2019s disease","volume":"90","author":"Chouliaras","year":"2010","journal-title":"Prog. Neurobiol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"9100","DOI":"10.1074\/jbc.M109.060061","article-title":"AMP-activated protein kinase signaling activation by resveratrol modulates amyloid-beta peptide metabolism","volume":"285","author":"Vingtdeux","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1212\/WNL.0000000000002035","article-title":"A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease","volume":"85","author":"Turner","year":"2015","journal-title":"Neurology"},{"key":"ref_128","first-page":"15","article-title":"Resveratrol inhibits beta-amyloid oligomeric cytotoxicity but does not prevent oligomer formation","volume":"31","author":"Feng","year":"2009","journal-title":"Neurotoxicology"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"8370","DOI":"10.1523\/JNEUROSCI.21-21-08370.2001","article-title":"The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse","volume":"21","author":"Lim","year":"2001","journal-title":"J. Neurosci."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"113469","DOI":"10.1016\/j.ecoenv.2022.113469","article-title":"Curcumin protects against manganese-induced neurotoxicity in rat by regulating oxidative stress-related gene expression via H3K27 acetylation","volume":"236","author":"Yang","year":"2022","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s12264-016-0067-0","article-title":"Long-term cognitive improvement after benfotiamine administration in patients with Alzheimer\u2019s disease","volume":"32","author":"Pan","year":"2016","journal-title":"Neurosci. Bull."},{"key":"ref_132","doi-asserted-by":"crossref","unstructured":"Wang, Y., Wu, S., Li, Q., Lang, W., Li, W., Jiang, X., Wan, Z., Chen, J., and Wang, H. (2022). Epigallocatechin-3-gallate: A phytochemical as a promising drug candidate for the treatment of Parkinson\u2019s disease. Front. Pharmacol., 13.","DOI":"10.3389\/fphar.2022.977521"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.bbr.2014.05.068","article-title":"Effects of curcumin on learning and memory deficits, BDNF, and ERK protein expression in rats exposed to chronic unpredictable stress","volume":"271","author":"Liu","year":"2014","journal-title":"Behav. Brain Res."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12937-016-0179-4","article-title":"Potential neuroprotective properties of epigallocatechin-3-gallate (EGCG)","volume":"15","author":"Singh","year":"2016","journal-title":"Nutr. J."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.jconrel.2020.11.021","article-title":"Neurodegenerative diseases and effective drug delivery: A review of challenges and novel therapeutics","volume":"330","author":"Akhtar","year":"2021","journal-title":"J. Control. Release"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12987-021-00250-7","article-title":"Epigenetics in blood-brain barrier disruption","volume":"18","author":"Ihezie","year":"2021","journal-title":"Fluids Barriers CNS"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1152\/physrev.00012.2010","article-title":"Epigenetic regulation of gene expression in physiological and pathological brain processes","volume":"91","author":"Kim","year":"2011","journal-title":"Physiol. Rev."},{"key":"ref_138","doi-asserted-by":"crossref","unstructured":"Edelmann, M.J., and Maegawa, G.H.B. (2020). CNS-Targeting Therapies for Lysosomal Storage Diseases: Current Advances and Challenges. Front. Mol. Biosci., 7.","DOI":"10.3389\/fmolb.2020.559804"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s13148-022-01263-1","article-title":"Ethical implications of epigenetics in the era of personalized medicine","volume":"14","author":"Berdasco","year":"2022","journal-title":"Clin. Epigenetics"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s41571-019-0267-4","article-title":"Combining epigenetic drugs with other therapies for solid tumours-past lessons and future promise","volume":"17","author":"Morel","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1158\/2159-8290.CD-12-0076","article-title":"Emerging epigenetic targets and therapies in cancer medicine","volume":"2","author":"Popovic","year":"2012","journal-title":"Cancer Discov."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1038\/nn.2671","article-title":"Dynamic epigenetic regulation in neurons: Enzymes, stimuli and signaling pathways","volume":"13","author":"Riccio","year":"2010","journal-title":"Nat. Neurosci."},{"key":"ref_143","doi-asserted-by":"crossref","unstructured":"Linares, C.A., Varghese, A., Ghose, A., Shinde, S.D., Adeleke, S., Sanchez, E., Sheriff, M., Chargari, C., Rassy, E., and Boussios, S. (2023). Hallmarks of the Tumour Microenvironment of Gliomas and Its Interaction with Emerging Immunotherapy Modalities. Int. J. Mol. Sci., 24.","DOI":"10.20944\/preprints202307.0043.v1"},{"key":"ref_144","doi-asserted-by":"crossref","unstructured":"Sulewska, A., Pilz, L., Manegold, C., Ramlau, R., Charkiewicz, R., and Niklinski, J. (2023). A Systematic Review of Progress toward Unlocking the Power of Epigenetics in NSCLC: Latest Updates and Perspectives. Cells, 12.","DOI":"10.3390\/cells12060905"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.4103\/1673-5374.332145","article-title":"Targeting the epigenome to treat neurodegenerative diseases or delay their onset: A perspective","volume":"17","author":"Coppede","year":"2022","journal-title":"Neural Regen. Res."},{"key":"ref_146","doi-asserted-by":"crossref","unstructured":"Kharod, S.C., Kang, S.K., and Kadam, S.D. (2019). Off-Label Use of Bumetanide for Brain Disorders: An Overview. Front. Neurosci., 13.","DOI":"10.3389\/fnins.2019.00310"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrd4360","article-title":"Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders","volume":"13","author":"Falkenberg","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_148","doi-asserted-by":"crossref","unstructured":"Boussios, S., Ozturk, M.A., Moschetta, M., Karathanasi, A., Zakynthinakis-Kyriakou, N., Katsanos, K.H., Christodoulou, D.K., and Pavlidis, N. (2019). The Developing Story of Predictive Biomarkers in Colorectal Cancer. J. Pers. Med., 9.","DOI":"10.3390\/jpm9010012"},{"key":"ref_149","doi-asserted-by":"crossref","unstructured":"Shaman, J.A. (2024). The Future of Pharmacogenomics: Integrating Epigenetics, Nutrigenomics, and Beyond. J. Pers. Med., 14.","DOI":"10.3390\/jpm14121121"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/B978-0-323-85538-9.00005-5","article-title":"The definition of precision medicine in neurodegenerative disorders and the one disease-many diseases tension","volume":"192","author":"Olszewska","year":"2023","journal-title":"Handb. Clin. Neurol."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/caim.12375","article-title":"Is open innovation always the best for SMEs? An exploratory analysis at the project level","volume":"29","author":"Marullo","year":"2020","journal-title":"Creat. Innov. Manag."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1039\/D4FO04715J","article-title":"Dietary polyphenols for tumor therapy: Bioactivities, nano-therapeutic systems and delivery strategies","volume":"16","author":"Wang","year":"2025","journal-title":"Food Funct."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"557","DOI":"10.3390\/pharmaceutics6040557","article-title":"Smuggling Drugs into the Brain: An Overview of Ligands Targeting Transcytosis for Drug Delivery across the Blood-Brain Barrier","volume":"6","author":"Georgieva","year":"2014","journal-title":"Pharmaceutics"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/s11912-024-01524-7","article-title":"Antibody Drug Conjugates in Urological Cancers: A Review of the Current Landscape","volume":"26","author":"Ghose","year":"2024","journal-title":"Curr. Oncol. Rep."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"102321","DOI":"10.1016\/j.arr.2024.102321","article-title":"Advances in gene therapy approaches targeting neuro-inflammation in neurodegenerative diseases","volume":"98","author":"Singh","year":"2024","journal-title":"Ageing Res. Rev."},{"key":"ref_156","doi-asserted-by":"crossref","unstructured":"Wang, R.C., and Wang, Z. (2023). Precision Medicine: Disease Subtyping and Tailored Treatment. Cancers, 15.","DOI":"10.3390\/cancers15153837"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/s41583-022-00673-7","article-title":"Gene therapy for chronic pain: Emerging opportunities in target-rich peripheral nociceptors","volume":"24","author":"Ovsepian","year":"2023","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"4195","DOI":"10.1021\/mp400247t","article-title":"Improved lentiviral transduction of ALS motoneurons in vivo via dual targeting","volume":"10","author":"Ovsepian","year":"2013","journal-title":"Mol. Pharm."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.molmed.2016.09.004","article-title":"Circumventing Brain Barriers: Nanovehicles for Retroaxonal Therapeutic Delivery","volume":"22","author":"Ovsepian","year":"2016","journal-title":"Trends Mol. Med."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/s41573-020-0077-5","article-title":"Targeting the epigenetic regulation of antitumour immunity","volume":"19","author":"Hogg","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"e42054","DOI":"10.1016\/j.heliyon.2025.e42054","article-title":"Precision oncology through next generation sequencing in hepatocellular carcinoma","volume":"11","author":"Shinde","year":"2025","journal-title":"Heliyon"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1007\/s12282-024-01628-9","article-title":"Applying whole-genome and whole-exome sequencing in breast cancer: A review of the landscape","volume":"31","author":"Ganatra","year":"2024","journal-title":"Breast Cancer"},{"key":"ref_163","doi-asserted-by":"crossref","unstructured":"Hamamoto, R., Komatsu, M., Takasawa, K., Asada, K., and Kaneko, S. (2019). Epigenetics Analysis and Integrated Analysis of Multiomics Data, Including Epigenetic Data, Using Artificial Intelligence in the Era of Precision Medicine. Biomolecules, 10.","DOI":"10.3390\/biom10010062"},{"key":"ref_164","doi-asserted-by":"crossref","unstructured":"David-Olawade, C.A., Olawade, D.B., Vanderbloemen, L., Rotifa, O.B., Fidelis, S.C., Egbon, E., Akpan, A.O., Adeleke, S., Ghose, A., and Boussios, S. (2025). AI-Driven Advances in Low-Dose Imaging and Enhancement\u2014A Review. Diagnostics, 15.","DOI":"10.3390\/diagnostics15060689"},{"key":"ref_165","doi-asserted-by":"crossref","unstructured":"Tapper, W., Carneiro, G., Mikropoulos, C., Thomas, S.A., Evans, P.M., and Boussios, S. (2024). The Application of Radiomics and AI to Molecular Imaging for Prostate Cancer. J. Pers. Med., 14.","DOI":"10.3390\/jpm14030287"},{"key":"ref_166","doi-asserted-by":"crossref","unstructured":"Olawade, D.B., Weerasinghe, K., Mathugamage, M.D.D.E., Odetayo, A., Aderinto, N., Teke, J., and Boussios, S. (2025). Enhancing Ophthalmic Diagnosis and Treatment with Artificial Intelligence. Medicina, 61.","DOI":"10.3390\/medicina61030433"},{"key":"ref_167","doi-asserted-by":"crossref","unstructured":"Olawade, D.B., Clement David-Olawade, A., Adereni, T., Egbon, E., Teke, J., and Boussios, S. (2025). Integrating AI into Cancer Immunotherapy\u2014A Narrative Review of Current Applications and Future Directions. Diseases, 13.","DOI":"10.3390\/diseases13010024"},{"key":"ref_168","doi-asserted-by":"crossref","unstructured":"Olawade, D.B., Teke, J., Adeleye, K.K., Egbon, E., Weerasinghe, K., Ovsepian, S.V., and Boussios, S. (2024). AI-Guided Cancer Therapy for Patients with Coexisting Migraines. Cancers, 16.","DOI":"10.3390\/cancers16213690"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.2174\/1568026619666191202155738","article-title":"Neuroprotection with Natural Antioxidants and Nutraceuticals in the Context of Brain Cell Degeneration: The Epigenetic Connection","volume":"19","author":"Carrera","year":"2019","journal-title":"Curr. Top. Med. Chem."},{"key":"ref_170","doi-asserted-by":"crossref","unstructured":"Sahafnejad, Z., Ramazi, S., and Allahverdi, A. (2023). An Update of Epigenetic Drugs for the Treatment of Cancers and Brain Diseases: A Comprehensive Review. Genes, 14.","DOI":"10.3390\/genes14040873"},{"key":"ref_171","doi-asserted-by":"crossref","unstructured":"Chiu, F.Y., and Yen, Y. (2023). Imaging biomarkers for clinical applications in neuro-oncology: Current status and future perspectives. Biomark. Res., 11.","DOI":"10.1186\/s40364-023-00476-7"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.7150\/thno.72126","article-title":"Autoantibodies targeting neuronal proteins as biomarkers for neurodegenerative diseases","volume":"12","author":"Kocurova","year":"2022","journal-title":"Theranostics"},{"key":"ref_173","doi-asserted-by":"crossref","unstructured":"Pokorn\u00e1, M., \u010cern\u00e1, M., Boussios, S., Ovsepian, S.V., and O\u2019Leary, V.B. (2024). lncRNA Biomarkers of Glioblastoma Multiforme. Biomedicines, 12.","DOI":"10.3390\/biomedicines12050932"},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"104289","DOI":"10.1016\/j.drudis.2025.104289","article-title":"Molecular biomarkers of glial activation and injury in epilepsy","volume":"30","author":"Kalsariya","year":"2025","journal-title":"Drug Discov. Today"},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"17588359241233225","DOI":"10.1177\/17588359241233225","article-title":"Diagnostic biomarkers in ovarian cancer: Advances beyond CA125 and HE4","volume":"16","author":"Ghose","year":"2024","journal-title":"Ther. Adv. Med. Oncol."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"17588359231192402","DOI":"10.1177\/17588359231192402","article-title":"Predictive biomarkers for immune checkpoint inhibitor response in urothelial cancer","volume":"15","author":"Parent","year":"2023","journal-title":"Ther. Adv. Med. Oncol."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.bioana.2024.06.004","article-title":"A comprehensive study on epigenetic signatures to monitor disease progression and the response to therapy in breast cancer","volume":"1","author":"Parikh","year":"2024","journal-title":"Biomed. Anal."},{"key":"ref_178","doi-asserted-by":"crossref","unstructured":"Zakari, S., Niels, N.K., Olagunju, G.V., Nnaji, P.C., Ogunniyi, O., Tebamifor, M., Israel, E.N., Atawodi, S.E., and Ogunlana, O.O. (2024). Emerging biomarkers for non-invasive diagnosis and treatment of cancer: A systematic review. Front. Oncol., 14.","DOI":"10.3389\/fonc.2024.1405267"},{"key":"ref_179","doi-asserted-by":"crossref","unstructured":"Hernaiz, A., Toivonen, J.M., Bolea, R., and Mart\u00edn-Burriel, I. (2022). Epigenetic Changes in Prion and Prion-like Neurodegenerative Diseases: Recent Advances, Potential as Biomarkers, and Future Perspectives. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232012609"},{"key":"ref_180","doi-asserted-by":"crossref","unstructured":"Ilieva, M.S. (2024). Non-Coding RNAs in Neurological and Neuropsychiatric Disorders: Unraveling the Hidden Players in Disease Pathogenesis. Cells, 13.","DOI":"10.3390\/cells13121063"},{"key":"ref_181","doi-asserted-by":"crossref","unstructured":"Zimmer-Bensch, G., and Zempel, H. (2021). DNA Methylation in Genetic and Sporadic Forms of Neurodegeneration: Lessons from Alzheimer\u2019s, Related Tauopathies and Genetic Tauopathies. Cells, 10.","DOI":"10.20944\/preprints202105.0717.v1"},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s40035-023-00339-z","article-title":"Employing nanoparticle tracking analysis of salivary neuronal exosomes for early detection of neurodegenerative diseases","volume":"12","author":"Sharma","year":"2023","journal-title":"Transl. Neurodegener."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/10\/4929\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:36:16Z","timestamp":1760031376000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/10\/4929"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,21]]},"references-count":182,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,5]]}},"alternative-id":["ijms26104929"],"URL":"https:\/\/doi.org\/10.3390\/ijms26104929","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,21]]}}}